PAPER Teipel SJ, Walter M, Likitjaroen Y, Schönknecht P, Gruber O
SEARCH RESULTS
329967 RESULTS
PAPER Ueckert S, Plan EL, Ito K, Karlsson MO, Corrigan B, Hooker AC, Alzheimer’s Disease Neuroimaging Initiative
Improved utilization of ADAS-cog assessment data through item response theory based pharmacometric modeling.
Pharm Res. 2014 Aug;31(8):2152-65. Epub 2014 Mar 5 PubMed: 24595495PAPER Li JJ, Dolios G, Wang R, Liao FF
Soluble beta-amyloid peptides, but not insoluble fibrils, have specific effect on neuronal microRNA expression.
PLoS One. 2014;9(3):e90770. Epub 2014 Mar 4 PubMed: 24595404PAPER Gao N, Sun H, Dong K, Ren J, Duan T, Xu C, Qu X
Transition-metal-substituted polyoxometalate derivatives as functional anti-amyloid agents for Alzheimer's disease.
Nat Commun. 2014 Mar 4;5:3422. PubMed: 24595206PAPER Lodeiro M, Ibáñez C, Cifuentes A, Simó C, Cedazo-Mínguez Á
Decreased cerebrospinal fluid levels of L-carnitine in non-apolipoprotein E4 carriers at early stages of Alzheimer's disease.
J Alzheimers Dis. 2014;41(1):223-32. PubMed: 24595197PAPER Hanger DP, Lau DH, Phillips EC, Bondulich MK, Guo T, Woodward BW, Pooler AM, Noble W
Intracellular and extracellular roles for tau in neurodegenerative disease.
J Alzheimers Dis. 2014;40 Suppl 1:S37-45. PubMed: 24595196PAPER Frisardi V
Impact of metabolic syndrome on cognitive decline in older age: protective or harmful, where is the pitfall?
J Alzheimers Dis. 2014;41(1):163-7. PubMed: 24595195PAPER Sahara N, Ren Y, Ward S, Binder LI, Suhara T, Higuchi M
Tau oligomers as potential targets for early diagnosis of tauopathy.
J Alzheimers Dis. 2014;40 Suppl 1:S91-6. PubMed: 24595194PAPER Harris CJ, Voss K, Murchison C, Ralle M, Frahler K, Carter R, Rhoads A, Lind B, Robinson E, Quinn JF
Oral zinc reduces amyloid burden in Tg2576 mice.
J Alzheimers Dis. 2014;41(1):179-92. PubMed: 24595193PAPER Frings L, Yew B, Flanagan E, Lam BY, Hüll M, Huppertz HJ, Hodges JR, Hornberger M
Longitudinal grey and white matter changes in frontotemporal dementia and Alzheimer's disease.
PLoS One. 2014;9(3):e90814. Epub 2014 Mar 3 PubMed: 24595028PAPER Hu NW, Nicoll AJ, Zhang D, Mably AJ, O'Malley T, Purro SA, Terry C, Collinge J, Walsh DM, Rowan MJ
mGlu5 receptors and cellular prion protein mediate amyloid-β-facilitated synaptic long-term depression in vivo.
Nat Commun. 2014 Mar 4;5:3374. PubMed: 24594908PAPER Frenzel D, Glück JM, Brener O, Oesterhelt F, Nagel-Steger L, Willbold D
Immobilization of homogeneous monomeric, oligomeric and fibrillar Aβ species for reliable SPR measurements.
PLoS One. 2014;9(3):e89490. Epub 2014 Mar 3 PubMed: 24594736PAPER Nilsen LH, Witter MP, Sonnewald U
Neuronal and astrocytic metabolism in a transgenic rat model of Alzheimer's disease.
J Cereb Blood Flow Metab. 2014 May;34(5):906-14. Epub 2014 Mar 5 PubMed: 24594625PAPER Fang L, Fang X, Gou S, Lupp A, Lenhardt I, Sun Y, Huang Z, Chen Y, Zhang Y, Fleck C
Design, synthesis and biological evaluation of D-ring opened galantamine analogs as multifunctional anti-Alzheimer agents.
Eur J Med Chem. 2014 Apr 9;76:376-86. Epub 2014 Feb 14 PubMed: 24594525PAPER Kia Y, Osman H, Suresh Kumar R, Basiri A, Murugaiyah V
Synthesis and discovery of highly functionalized mono- and bis-spiro-pyrrolidines as potent cholinesterase enzyme inhibitors.
Bioorg Med Chem Lett. 2014 Apr 1;24(7):1815-9. Epub 2014 Feb 15 PubMed: 24594354Current Filters
No filters selected